Balance Sheet Sika AG

Equities

SIKA

CH0418792922

Specialty Chemicals

Market Closed - Swiss Exchange Other stock markets 16:31:31 06/03/2026 GMT			5-day change	1st Jan Change
141.75 ^CHF	-3.64%		-9.97%	-12.82%

03-03	From Calm to Caution
03-03	Sika Signs Commercial Partnership With Giatec Scientific Inc	CI

3f94cd14f2505c944675a4.VSwK8bxgDY8ntGV6ZvlI4InkdBnTx1PuvxDPiTqob34.GmBziesJfe19gAMpIYlwpczXESq7ixWNiSSB5GvpDjw_TTiX5VZV7EL2Ag

Published financial data: SIKA AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	9.25B	10.49B	11.24B	11.76B	11.2B
Total Revenues	9.25B	10.49B	11.24B	11.76B	11.2B
Cost of Goods Sold, Total	4.46B	5.31B	5.21B	5.35B	5.05B
Gross Profit	4.79B	5.18B	6.02B	6.42B	6.15B
Selling General & Admin Expenses, Total	1.67B	1.75B	2.06B	2.2B	2.24B
Depreciation & Amortization - (IS)	367M	384M	485M	556M	542M
Other Operating Expenses	1.36B	1.55B	1.73B	1.93B	1.85B
Other Operating Expenses, Total	3.4B	3.69B	4.28B	4.69B	4.63B
Operating Income	1.39B	1.49B	1.75B	1.72B	1.52B
Interest Expense, Total	-55.2M	-57.4M	-162M	-179M	-151M
Interest And Investment Income	11.5M	19M	30.9M	26.6M	17.3M
Net Interest Expenses	-43.7M	-38.4M	-131M	-152M	-134M
Income (Loss) On Equity Invest.	400K	400K	1.1M	3.6M	-
Currency Exchange Gains (Loss)	-13.9M	-	-	-	-
Other Non Operating Income (Expenses)	3.1M	-41.5M	-79M	4.8M	3.1M
EBT, Excl. Unusual Items	1.34B	1.41B	1.54B	1.58B	1.39B
Merger & Related Restructuring Charges	-7.1M	-79.7M	-193M	-17.7M	-2.4M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-	166M	-	-	-
Asset Writedown	-	-	-10.3M	-	-29.8M
Other Unusual Items	6.3M	-	-	-	-
EBT, Incl. Unusual Items	1.34B	1.5B	1.34B	1.56B	1.36B
Income Tax Expense	287M	336M	274M	315M	310M
Earnings From Continuing Operations	1.05B	1.16B	1.06B	1.25B	1.05B
Net Income to Company	1.05B	1.16B	1.06B	1.25B	1.05B
Minority Interest	-600K	-	-600K	-2.1M	-1.3M
Net Income - (IS)	1.05B	1.16B	1.06B	1.25B	1.04B
Net Income to Common Incl Extra Items	1.05B	1.16B	1.06B	1.25B	1.04B
Net Income to Common Excl. Extra Items	1.05B	1.16B	1.06B	1.25B	1.04B
Per Share Items
Net EPS - Basic	7.39	7.57	6.82	7.76	6.51
Basic EPS - Continuing Operations	7.39	7.57	6.82	7.76	6.51
Basic Weighted Average Shares Outstanding	142M	154M	156M	160M	160M
Net EPS - Diluted	6.6	7.29	6.65	7.76	6.5
Diluted EPS - Continuing Operations	6.6	7.29	6.65	7.76	6.5
Diluted Weighted Average Shares Outstanding	160M	160M	161M	161M	161M
Normalized Basic EPS	5.88	5.75	6.17	6.14	5.4
Normalized Diluted EPS	5.21	5.5	5.99	6.14	5.4
Dividend Per Share	2.9	3.2	3.3	3.6	3.7
Payout Ratio	33.83	38.35	46.36	21.25	27.66
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	1.66B	1.78B	2.11B	2.14B	1.94B
EBITA	1.5B	1.6B	1.91B	1.92B	1.7B
EBIT	1.39B	1.49B	1.75B	1.72B	1.52B
EBITDAR	1.7B	1.82B	2.16B	2.19B	2B
Effective Tax Rate - (Ratio)	21.5	22.41	20.49	20.18	22.9
Total Current Taxes	294M	365M	381M	372M	330M
Total Deferred Taxes	500K	-29.3M	-116M	-48M	-17.5M
Normalized Net Income	835M	882M	962M	986M	866M
Interest on Long-Term Debt	48.6M	48.9M	125M	150M	136M
Non-Cash Pension Expense	200K	4.9M	8.1M	8M	6.7M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	214M	232M	270M	278M	281M
Net Rental Expense, Total	33.1M	42.1M	48M	54.2M	54.4M
Imputed Operating Lease Interest Expense	3.7M	5.05M	12.66M	13.37M	11.66M
Imputed Operating Lease Depreciation	29.4M	37.05M	35.34M	40.83M	42.74M
Stock-Based Comp., SG&A Exp. (Total)	38.8M	21.6M	31.6M	26.8M	19.7M
Total Stock-Based Compensation	38.8M	21.6M	31.6M	26.8M	19.7M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	1.18B	1.87B	644M	708M	802M
Trading Asset Securities, Total	4.5M	2.8M	4.3M	5.4M	5.8M
Total Cash And Short Term Investments	1.18B	1.88B	648M	713M	808M
Accounts Receivable, Total	1.58B	1.72B	2.01B	2.18B	2.01B
Other Receivables	-	-	-	-	175M
Notes Receivable	9.9M	15.9M	12.3M	18.8M	12.1M
Total Receivables	1.59B	1.74B	2.02B	2.19B	2.2B
Inventory	1.16B	1.21B	1.24B	1.35B	1.24B
Prepaid Expenses	190M	190M	244M	274M	121M
Other Current Assets, Total	50.2M	6.8M	47.2M	34.2M	45.9M
Total Current Assets	4.17B	5.02B	4.2B	4.56B	4.41B
Gross Property Plant And Equipment	3.95B	4.1B	4.62B	5.15B	5.25B
Accumulated Depreciation	-2.17B	-2.28B	-2.37B	-2.69B	-2.81B
Net Property Plant And Equipment	1.78B	1.82B	2.26B	2.46B	2.44B
Long-term Investments	73.6M	69M	86.9M	103M	86M
Goodwill	3.29B	3.23B	6.2B	6.57B	6.14B
Other Intangibles, Total	1.08B	1B	2.02B	2.05B	1.8B
Loans Receivable Long-Term	17.2M	14.3M	14.5M	23.8M	21.5M
Deferred Tax Assets Long-Term	142M	145M	189M	151M	136M
Other Long-Term Assets, Total	152M	18.4M	78.5M	61.5M	116M
Total Assets	10.7B	11.32B	15.05B	15.98B	15.15B
Liabilities
Accounts Payable, Total	1.03B	1.02B	1.11B	1.21B	1.18B
Accrued Expenses, Total	516M	485M	674M	620M	556M
Current Portion of Long-Term Debt	251M	216M	1.02B	214M	1.29B
Current Portion of Leases	73.5M	78.1M	112M	114M	116M
Current Income Taxes Payable	170M	206M	365M	368M	317M
Unearned Revenue Current, Total	3.9M	3.9M	3.8M	4.2M	4.2M
Other Current Liabilities	40.1M	36M	128M	53.8M	62.5M
Total Current Liabilities	2.09B	2.04B	3.42B	2.59B	3.53B
Long-Term Debt	3.15B	3.38B	4.44B	5.12B	3.81B
Long-Term Leases	244M	256M	287M	310M	322M
Unearned Revenue Non Current	36.4M	36.1M	35.7M	41M	37.9M
Pension & Other Post Retirement Benefits	323M	240M	329M	357M	331M
Deferred Tax Liability Non Current	367M	322M	405M	339M	312M
Other Non Current Liabilities	95.6M	78.4M	200M	183M	142M
Total Liabilities	6.3B	6.35B	9.12B	8.93B	8.48B
Common Stock, Total	1.4M	1.5M	1.6M	1.6M	1.6M
Additional Paid In Capital	437M	1.88B	3.14B	2.88B	2.59B
Retained Earnings	4.96B	4.33B	4.83B	5.89B	6.74B
Treasury Stock	-10.7M	-15.1M	-11.9M	-8.8M	-7.5M
Comprehensive Income and Other	-995M	-1.23B	-2.04B	-1.73B	-2.67B
Total Common Equity	4.39B	4.97B	5.92B	7.03B	6.66B
Minority Interest	2.1M	900K	12.8M	14M	10.3M
Total Equity	4.4B	4.97B	5.93B	7.05B	6.67B
Total Liabilities And Equity	10.7B	11.32B	15.05B	15.98B	15.15B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	143M	154M	160M	160M	160M
ECS Total Common Shares Outstanding	143M	154M	160M	160M	160M
Book Value / Share	30.72	32.32	36.9	43.83	41.49
Tangible Book Value	20.8M	737M	-2.3B	-1.58B	-1.28B
Tangible Book Value Per Share	0.15	4.8	-14.36	-9.87	-7.96
Total Debt	3.72B	3.93B	5.87B	5.75B	5.54B
Net Debt	2.54B	2.05B	5.22B	5.04B	4.73B
Debt Equivalent of Unfunded Proj. Benefit Obligation	52.4M	22.8M	136M	162M	85.7M
Debt Equivalent Oper. Leases	265M	337M	384M	434M	435M
Minority Interest, Total (Incl. Fin. Div)	2.1M	900K	12.8M	14M	10.3M
Equity Method Investments, Total	9.2M	9.5M	19.1M	24.1M	2.9M
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	453M	496M	491M	539M	469M
Inventories - Work In Process, Total	77.4M	75.5M	70.5M	71.1M	68.9M
Inventories - Finished Goods, Total	628M	642M	679M	739M	699M
Machinery, Total	3.13B	3.18B	3.49B	3.81B	3.79B
Full Time Employees	26.27K	27.71K	32.51K	33.51K	30.63K
Part Time Employees	787	-	1.03K	965	-
Accumulated Allowance for Doubtful Accounts (Supple)	80.6M	95.8M	101M	129M	121M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	1.05B	1.16B	1.06B	1.25B	1.04B
Depreciation & Amortization - CF	250M	261M	306M	342M	372M
Amortization of Goodwill and Intangible Assets - (CF)	106M	113M	165M	193M	179M
Depreciation & Amortization, Total	356M	373M	471M	534M	551M
Amortization of Deferred Charges, Total - (CF)	10.7M	11.2M	14.2M	21.1M	20.6M
(Gain) Loss From Sale Of Asset	-7.8M	-188M	-900K	-5.6M	-10.3M
Asset Writedown & Restructuring Costs	-	-	10.3M	-	-
Stock-Based Compensation (CF)	9.1M	10.5M	9.7M	10M	8.9M
Other Operating Activities, Total	-1.4M	77M	7.1M	114M	44.2M
Change in Other Net Operating Assets	-350M	-346M	71.9M	-177M	49.6M
Cash from Operations	1.06B	1.1B	1.65B	1.74B	1.71B
Capital Expenditure	-157M	-238M	-257M	-331M	-348M
Sale of Property, Plant, and Equipment	14.9M	31.4M	6.9M	18.9M	23.1M
Cash Acquisitions	-304M	-143M	-3.24B	-257M	-200M
Divestitures	-	212M	-	-	-
Sale (Purchase) of Intangible assets	-13.3M	-28M	-22.8M	-27.7M	-26.8M
Investment in Marketable and Equity Securities, Total	-9.1M	-3.4M	-7.3M	-8.3M	-500K
Other Investing Activities, Total	-	-	-	24.4M	17.3M
Cash from Investing	-469M	-169M	-3.52B	-581M	-535M
Long-Term Debt Issued, Total	5.1M	620M	4.27B	2.27B	1.96B
Total Debt Issued	5.1M	620M	4.27B	2.27B	1.96B
Long-Term Debt Repaid, Total	-363M	-336M	-2.89B	-2.62B	-2.28B
Total Debt Repaid	-363M	-336M	-2.89B	-2.62B	-2.28B
Issuance of Common Stock	41.7M	46.2M	39.2M	34.7M	-
Repurchase of Common Stock	-65.2M	-67M	-44.9M	-41.4M	-8.2M
Common Dividends Paid	-354M	-446M	-492M	-265M	-289M
Common & Preferred Stock Dividends Paid	-354M	-446M	-492M	-265M	-289M
Other Financing Activities, Total	-800K	-6.6M	-187M	-461M	-426M
Cash from Financing	-737M	-190M	695M	-1.08B	-1.04B
Foreign Exchange Rate Adjustments	-1.8M	-42.5M	-54.2M	-14.6M	-39.9M
Net Change in Cash	-144M	698M	-1.23B	63.6M	94.3M
Supplemental Items
Cash Interest Paid	36.6M	31.9M	98.8M	143M	132M
Cash Income Tax Paid (Refund)	315M	316M	373M	398M	408M
Levered Free Cash Flow	661M	861M	1.35B	875M	1.17B
Unlevered Free Cash Flow	695M	897M	1.45B	987M	1.27B
Change In Net Working Capital	409M	175M	-125M	315M	-102M
Net Debt Issued / Repaid	-358M	283M	1.38B	-351M	-316M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	8.48	8.46	8.29	6.95	6.1
Return on Total Capital	11.16	10.95	10.56	8.76	7.59
Return On Equity %	27.29	24.83	19.5	19.22	15.24
Return on Common Equity	27.29	24.84	19.51	19.23	15.25
Margin Analysis
Gross Profit Margin %	51.78	49.37	53.61	54.54	54.94
SG&A Margin	18.05	16.72	18.32	18.74	20
EBITDA Margin %	17.96	16.95	18.8	18.18	17.36
EBITA Margin %	16.17	15.28	17.02	16.3	15.16
EBIT Margin %	15.03	14.21	15.56	14.66	13.56
Income From Continuing Operations Margin %	11.33	11.08	9.45	10.61	9.33
Net Income Margin %	11.33	11.08	9.45	10.59	9.32
Net Avail. For Common Margin %	11.33	11.08	9.45	10.59	9.32
Normalized Net Income Margin	9.02	8.41	8.56	8.38	7.73
Levered Free Cash Flow Margin	7.14	8.2	12.04	7.44	10.47
Unlevered Free Cash Flow Margin	7.51	8.55	12.94	8.39	11.31
Asset Turnover
Asset Turnover	0.9	0.95	0.85	0.76	0.72
Fixed Assets Turnover	5.32	5.83	5.51	4.99	4.57
Receivables Turnover (Average Receivables)	6.3	6.37	6.03	5.62	5.35
Inventory Turnover (Average Inventory)	4.52	4.48	4.25	4.13	3.9
Short Term Liquidity
Current Ratio	1.99	2.46	1.23	1.77	1.25
Quick Ratio	1.32	1.76	0.78	1.12	0.85
Operating Cash Flow to Current Liabilities	0.51	0.54	0.48	0.67	0.48
Days Sales Outstanding (Average Receivables)	57.96	57.34	60.55	65.15	68.22
Days Outstanding Inventory (Average Inventory)	80.69	81.46	85.88	88.63	93.51
Average Days Payable Outstanding	71.38	69.71	73.98	77.84	88.31
Cash Conversion Cycle (Average Days)	67.27	69.09	72.45	75.94	73.42
Long Term Solvency
Total Debt/Equity	84.59	79.07	98.9	81.63	83.13
Total Debt / Total Capital	45.83	44.16	49.72	44.94	45.39
LT Debt/Equity	77.21	73.16	79.75	76.98	61.98
Long-Term Debt / Total Capital	41.83	40.85	40.1	42.38	33.84
Total Liabilities / Total Assets	58.92	56.12	60.58	55.89	55.99
EBIT / Interest Expense	25.19	25.97	10.82	9.63	10.04
EBITDA / Interest Expense	31.64	32.48	13.74	12.61	13.68
(EBITDA - Capex) / Interest Expense	28.79	28.33	12.15	10.77	11.38
Total Debt / EBITDA	2.13	2.11	2.64	2.55	2.68
Net Debt / EBITDA	1.45	1.1	2.35	2.23	2.29
Total Debt / (EBITDA - Capex)	2.34	2.42	2.99	2.98	3.22
Net Debt / (EBITDA - Capex)	1.6	1.26	2.66	2.61	2.75
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	17.45	13.4	7.12	4.67	-4.78
Gross Profit, 1 Yr. Growth %	11.04	8.11	16.31	6.49	-4.09
EBITDA, 1 Yr. Growth %	18.96	6.59	18.83	1.19	-9
EBITA, 1 Yr. Growth %	21.86	6.74	19.29	0.24	-11.38
EBIT, 1 Yr. Growth %	23.44	6.74	17.23	-1.34	-11.86
Earnings From Cont. Operations, 1 Yr. Growth %	27.08	10.87	-8.59	17.41	-16.22
Net Income, 1 Yr. Growth %	27.1	10.94	-8.65	17.28	-16.18
Normalized Net Income, 1 Yr. Growth %	26.29	5.19	9.02	2.51	-12.05
Diluted EPS Before Extra, 1 Yr. Growth %	26.5	10.47	-8.83	16.69	-16.24
Accounts Receivable, 1 Yr. Growth %	15.79	9.06	16.84	8.04	-7.48
Inventory, 1 Yr. Growth %	42.3	4.71	2.3	8.72	-8.26
Net Property, Plant and Equip., 1 Yr. Growth %	4.35	2.57	23.87	8.91	-0.6
Total Assets, 1 Yr. Growth %	9.25	5.72	32.97	6.17	-5.19
Tangible Book Value, 1 Yr. Growth %	-102.35	5.2K	-412.47	-31.09	-19.48
Common Equity, 1 Yr. Growth %	33.72	13.03	19.21	18.79	-5.35
Cash From Operations, 1 Yr. Growth %	-22.52	3.35	49.61	1.67	-2
Capital Expenditures, 1 Yr. Growth %	30.97	51.3	7.9	28.93	5.13
Levered Free Cash Flow, 1 Yr. Growth %	-40.94	29.61	57.25	-35.14	33.51
Unlevered Free Cash Flow, 1 Yr. Growth %	-39.72	28.34	62.18	-31.93	27.97
Dividend Per Share, 1 Yr. Growth %	16	10.34	3.12	9.09	2.78
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.82	15.41	10.21	5.89	-0.17
Gross Profit, 2 Yr. CAGR %	5.02	9.57	12.14	11.3	1.06
EBITDA, 2 Yr. CAGR %	11.65	12.82	12.55	9.66	-4.08
EBITA, 2 Yr. CAGR %	12.96	14.29	12.85	9.35	-5.79
EBIT, 2 Yr. CAGR %	13.1	15.04	11.87	7.55	-6.79
Earnings From Cont. Operations, 2 Yr. CAGR %	17.57	18.7	0.67	3.6	-0.82
Net Income, 2 Yr. CAGR %	18.05	18.74	0.67	3.51	-0.85
Normalized Net Income, 2 Yr. CAGR %	16.26	15.53	7.09	5.72	-5.1
Diluted EPS Before Extra, 2 Yr. CAGR %	17.16	18.22	0.36	3.14	-1.14
Accounts Receivable, 2 Yr. CAGR %	4.57	12.37	12.88	12.46	-0.02
Inventory, 2 Yr. CAGR %	15.62	22.06	3.5	5.46	-0.13
Net Property, Plant and Equip., 2 Yr. CAGR %	-0.54	3.46	12.72	16.15	4.05
Total Assets, 2 Yr. CAGR %	3.65	7.5	18.56	18.81	0.33
Tangible Book Value, 2 Yr. CAGR %	-86.98	-8.81	1.19K	46.56	-25.43
Common Equity, 2 Yr. CAGR %	18.59	22.94	16.08	19	6.03
Cash From Operations, 2 Yr. CAGR %	-6.37	-10.51	24.35	25.88	-0.18
Capital Expenditures, 2 Yr. CAGR %	-6.44	40.77	27.77	17.95	16.43
Levered Free Cash Flow, 2 Yr. CAGR %	-14.62	-12.27	42.76	0.81	-6.76
Unlevered Free Cash Flow, 2 Yr. CAGR %	-14.13	-11.82	44.29	4.89	-6.51
Dividend Per Share, 2 Yr. CAGR %	12.29	13.14	6.67	6.07	5.89
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	9.3	8.97	12.57	8.33	2.21
Gross Profit, 3 Yr. CAGR %	8.49	6.04	11.77	10.22	5.91
EBITDA, 3 Yr. CAGR %	12.47	10.07	14.79	8.63	3.02
EBITA, 3 Yr. CAGR %	13.28	11	15.94	8.48	1.92
EBIT, 3 Yr. CAGR %	12.65	11.1	15.78	7.28	0.61
Earnings From Cont. Operations, 3 Yr. CAGR %	15.13	15.3	8.8	5.97	-3.48
Net Income, 3 Yr. CAGR %	15.34	15.63	8.8	5.93	-3.52
Normalized Net Income, 3 Yr. CAGR %	13.52	12.62	13.32	5.54	-0.61
Diluted EPS Before Extra, 3 Yr. CAGR %	12.98	14.89	8.41	5.53	-3.77
Accounts Receivable, 3 Yr. CAGR %	6.03	6.05	13.84	11.32	5.38
Inventory, 3 Yr. CAGR %	13.1	11.86	15.08	5.21	0.67
Net Property, Plant and Equip., 3 Yr. CAGR %	13.53	0.49	9.86	11.44	10.28
Total Assets, 3 Yr. CAGR %	18.8	4.36	15.4	14.27	10.2
Tangible Book Value, 3 Yr. CAGR %	-24.43	-15.62	37.47	384.75	20.13
Common Equity, 3 Yr. CAGR %	38.73	16.71	21.68	16.98	10.26
Cash From Operations, 3 Yr. CAGR %	12.67	-3.24	6.21	17.88	15.8
Capital Expenditures, 3 Yr. CAGR %	-12.32	9.82	28.83	28.16	13.51
Levered Free Cash Flow, 3 Yr. CAGR %	19.38	-1.7	6.57	9.62	10.85
Unlevered Free Cash Flow, 3 Yr. CAGR %	19.77	-1.66	8.05	12.2	12.21
Dividend Per Share, 3 Yr. CAGR %	12.26	11.64	9.7	7.47	4.96
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	9.99	10.92	9.67	7.72	7.29
Gross Profit, 5 Yr. CAGR %	8.54	8.79	9.94	8.11	7.36
EBITDA, 5 Yr. CAGR %	11.78	10.83	12.59	9.91	6.84
EBITA, 5 Yr. CAGR %	12.4	11.3	13.2	10.34	6.7
EBIT, 5 Yr. CAGR %	11.81	10.62	12.44	9.67	6.16
Earnings From Cont. Operations, 5 Yr. CAGR %	13.1	12.36	9.11	10.46	4.84
Net Income, 5 Yr. CAGR %	13.23	12.56	9.23	10.62	4.83
Normalized Net Income, 5 Yr. CAGR %	12.21	10.49	11	9.81	5.56
Diluted EPS Before Extra, 5 Yr. CAGR %	12.3	11.54	7.75	10.04	4.49
Accounts Receivable, 5 Yr. CAGR %	8.62	7.66	8.72	8.57	8.12
Inventory, 5 Yr. CAGR %	14.03	10.7	9.15	9.26	8.74
Net Property, Plant and Equip., 5 Yr. CAGR %	13.12	11.34	13.2	6.48	7.5
Total Assets, 5 Yr. CAGR %	15.98	14.32	18.72	9.91	9.11
Tangible Book Value, 5 Yr. CAGR %	-59.48	-18.64	116.7	5.23	7.58
Common Equity, 5 Yr. CAGR %	8.48	7.97	29.18	17.62	15.16
Cash From Operations, 5 Yr. CAGR %	7.66	11.03	17.2	7.5	4.46
Capital Expenditures, 5 Yr. CAGR %	1.02	8.47	1.93	13	23.72
Levered Free Cash Flow, 5 Yr. CAGR %	4.39	11.74	28.37	-0.7	0.95
Unlevered Free Cash Flow, 5 Yr. CAGR %	4.96	12.15	29.16	0.92	1.9
Dividend Per Share, 5 Yr. CAGR %	12.63	11.58	9.99	9.37	8.16